HQL

Tekla Life Sciences Investors HQL

Net profit

EBITDA

P/E Ratio

Capitalization

Performance

Periode HQL THW THQ RVT BTO HQH DFP UTF ETG MYD
6M 37.84 % 22.36 % -7.28 % 20.96 % 18.41 % 24.26 % 11.87 % -2.38 % 20.49 % 7.21 %
YTD 22.52 % 16.95 % -4.35 % 2.60 % 1.42 % 16.45 % 6.73 % -1.65 % 16.66 % 2.00 %
1Y 8.50 % 0.39 % -19.73 % 2.28 % 4.83 % 2.00 % 2.18 % -6.77 % 10.48 % -5.56 %
3Y 15.46 % -0.54 % -4.19 % 27.34 % 12.75 % 5.70 % 18.77 % 10.58 % 38.88 % 7.86 %
5Y -9.49 % -10.43 % -3.15 % 18.48 % 57.73 % -10.04 % -22.62 % 3.43 % 38.43 % -20.92 %
10Y -33.92 % -15.89 % 2.77 % 33.55 % 43.68 % -38.24 % -4.93 % 18.67 % 35.35 % -24.75 %
From the beginning 8.07 % -35.15 % -10.90 % 61.60 % 79.10 % 93.85 % -13.71 % 19.14 % 6.45 % -28.67 %

Dividend

Tekla Life Sciences Investors

Abrdn World Healthcare Fund

Abrdn Healthcare Opportunities Fund

Royce Value Trust Inc.

John Hancock Financial Opportunities Fund

Abrdn Healthcare Investors

Flaherty & Crumrine Dynamic Preferred and Income Fund Inc.

Cohen & Steers Infrastructure Fund, Inc

Eaton Vance Tax-Advantaged Global Dividend Income Fund

BlackRock MuniYield Fund, Inc.